Global Demand for Wound Care Sealants Market

Would heal or wound repair is the physiological process by which the body repairs organ tissue or skin after injury. The wound healing process is divided in to four sequential steps namely hemostasis, inflammatory, proliferative and remodeling. Hemostasis is the first step that begins immediately after injury followed by fibrin clot formation. Clot formation takes place within fraction of minutes to control the blood loss. Hence, disturbed wound healing process can be related with increased mortality rate.

The improved understanding of wound healing has resulted in the rapid expansion of platelet gels, tissue sealants and use of growth factors. Tissue sealants provide an excellent alternative for the closure of surgical and non surgical wounds. These sealants are used for stopping the excessive blood loss during the injuries. Numerous biomaterials have been reported as wound sealant that includes keratin, dendrimers, mussel-adhesive proteins and in-situ forming hydrogels. Platelet gels also posses clot forming ability along with the release of growth factors. Recombinant platelet derived growth factor has been used in the treatment of dermal ulcers.

Download Brochure: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1821

Growth in the market is largely driven by the increase in number of surgical procedures. According to Center for Disease Control and Prevention (CDC), 51.4 million of surgeries were performed in the U.S. in 2012. The global wound care sealants market is segmented in to different product types that include glues, sealants, absorbable hemostats and adhesion prevention products. Both liquid and solids sealants have been developed for the variety of procedures and are effective by possessing strong adhesive properties. Biodegradable and biocompatible sealants are generally preferred during the surgical procedures.

Some of the major players capturing the market space include Baxter International, Covidien Ltd., CryoLife, CSL Behring and Davol (C.R.Bard). Other players include Genzyme, Ethicon (Jhonson and Jhonson), Takeda Pharmaceuticals, Pfizer Inc., and Zymogenetics.